Statin use is associated with a lower risk of mortality in patients with malignant breast cancer treated with anthracyclines. A global federated health database analysis

Back

ESC Professional Premium Access

Statin use is associated with a lower risk of mortality in patients with malignant breast cancer treated with anthracyclines. A global federated health database analysis

Session: Statins, bempedoic acid and ezetimibe: novel findings

Topic: Cardiotoxicity of Drugs

Speaker: Doctor T. Bucci (Liverpool, GB)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Tommaso Bucci

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

0 follower

6 more presentations in this session

Strike Early and Strike Strong: application of a strategy comprising first-line combination of high-intensity statins and ezetimibe for patients with acute myocardial infarction in routine practice

Speaker: Professor F. Schiele (Besancon, FR)

The impact of statin intensity on long-term outcomes in elderly patients with acute myocardial infarction who have undergone percutaneous coronary intervention

Speaker: Assistant Professor J. Choe (Pusan, KR)

Moderate-intensity statin plus ezetimibe combination therapy versus high-intensity statin monotherapy according to baseline LDL-C levels: a prespecified subgroup analysis of RACING Trial

Speaker: Associate Professor S. Hong (Seoul, KR)

Improving statins effectiveness by targeting baseline LDL cholesterol in type 2 diabetes mellitus, a systematic review and meta-analysis

Speaker: Mrs N. Soroush (Rotterdam, NL)

Therapeutic gaps in low-density lipoprotein cholesterol management have narrowed over time but remain wide: a wide study of 40,141 acute coronary syndrome patients from 2016 to 2021

Speaker: Doctor G. Tan (Shatin, HK)

Access the full session

Statins, bempedoic acid and ezetimibe: novel findings

Speakers: Doctor T. Bucci, Professor F. Schiele, Assistant Professor J. Choe, Associate Professor S. Hong, Mrs N. Soroush...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Statin use is associated with a lower risk of mortality in patients with malignant breast cancer treated with anthracyclines. A global federated health database analysis

About the speaker

Doctor Tommaso Bucci

6 more presentations in this session

Strike Early and Strike Strong: application of a strategy comprising first-line combination of high-intensity statins and ezetimibe for patients with acute myocardial infarction in routine practice

The impact of statin intensity on long-term outcomes in elderly patients with acute myocardial infarction who have undergone percutaneous coronary intervention

Moderate-intensity statin plus ezetimibe combination therapy versus high-intensity statin monotherapy according to baseline LDL-C levels: a prespecified subgroup analysis of RACING Trial

Improving statins effectiveness by targeting baseline LDL cholesterol in type 2 diabetes mellitus, a systematic review and meta-analysis

Therapeutic gaps in low-density lipoprotein cholesterol management have narrowed over time but remain wide: a wide study of 40,141 acute coronary syndrome patients from 2016 to 2021

Access the full session

Statins, bempedoic acid and ezetimibe: novel findings

About the event

ESC Congress 2023

ESC 365 is supported by